Characterization of Monoclonal Antibodies Which Recognize Specific Cell Surface Determinants on Salmonella Typhimurium

  • Eleanor S. Metcalf
  • Alison D. O’Brien
  • Moira A. Laveck
  • William E. Biddison
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 162)


Murine typhoid, a naturally occurring disease in mice caused by Salmonella typhimurium, is a good experimental model with which to study the interactions between host and parasite and is especially important since the pathogenesis of this disease is similar to typhoid fever in man (1). Although the role of the immune system in the regulation of this disease has not been studied extensively, previous studies have suggested that the murine immune response to S. typhimurium was primarily regulated by T cells and macrophages (2). However, recent observations suggest that B cells, hence protective antibodies, also play an important role in resistance (3–5). Nevertheless, the identification of the salmonella cell surface antigens towards which these protective antibodies are directed remains controversial. One approach to the identification of these antigenic determinants would be to generate large quantities of antibody directed against a specific bacterial cell surface determinant and to use these antibodies in passive transfer experiments to determine their role in the protection of the host from murine typhoid.


Typhoid Fever Antigenic Determinant Protective Antibody Good Experimental Model Cell Surface Determinant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wilson, G.S. and Miles, A. (1975). In: Topley and Wilson’s Principles of Bacteriology and Immunity. Vol. I. Academic Press, NY. p. 939.Google Scholar
  2. 2.
    Collins, F.M. (1974). Bacteriol. Rev. 38:371.PubMedGoogle Scholar
  3. 3.
    Kuusi, N., Nurminen, M., Saxen, H., Valtonen, M. and Makela, P.H. (1979). Infect. Immun. 25:857.PubMedGoogle Scholar
  4. 4.
    Svenson, S.B. and Lindberg, A.A. (1979). J. Immunol. Methods 25:323.PubMedCrossRefGoogle Scholar
  5. 5.
    O’Brien, A.D., Scher, I. and Metcalf, E.S. (1981). J. Immunol. 126:1368.PubMedGoogle Scholar
  6. 6.
    Köhler, G. and Milstein, C. (1975). Nature 256:495.PubMedCrossRefGoogle Scholar
  7. 7.
    Metcalf, E S. and O’Brien, A.D. (1981). Infect. Immun. 31:33.PubMedGoogle Scholar
  8. 8.
    Ozato, K., Mayer, N. and Sachs, D.H. (1980). J. Immunol. 124:533.PubMedGoogle Scholar
  9. 9.
    Nikaido, H., Leventhal, M., Nikaido, K. and Nakane, K. (1967). PNAS 57:1825.PubMedCrossRefGoogle Scholar
  10. 10.
    Brodsky, F.M., Parham, P., Barnstasle, C.J., Crumpton, M.J. and Bodmer, W.F. (1979). Immunol. Rev. 47:3.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Eleanor S. Metcalf
    • 1
  • Alison D. O’Brien
    • 1
  • Moira A. Laveck
    • 1
  • William E. Biddison
    • 1
  1. 1.Department of Microbiology, Uniformed ServicesUniversity School of Medicine, and Immunology Branch, NCI, NIHBethesdaUSA

Personalised recommendations